TESARO Announces Lonnie Moulder and Mary Lynne Hedley Named EY Entrepreneurs of the Year® New England
June 28 2017 - 9:00AM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, is proud to announce Lonnie Moulder, CEO, and Mary Lynne
Hedley, Ph.D., President and COO, have been named EY Entrepreneurs
of the Year® in Life Sciences Development for the New England
program. The awards program recognizes entrepreneurs who
demonstrate excellence and extraordinary success in such areas as
innovation, financial performance and personal commitment to their
businesses and communities.
“On behalf of all TESARO associates, we are
honored to accept this award in support of people bravely facing
cancer. They are at the heart of our mission, and everything we do
each and every day is for the patients we serve,” said Mary Lynne
Hedley, Ph.D., President and COO of TESARO. “We are grateful to be
in a position where we can make a meaningful difference in the
lives of patients. This award is a true validation of the work
TESARO associates are doing each and every day.”
“The company’s success to date would not have
been possible without the drive and collaboration of TESARO
associates and the strategic partnerships we’ve developed across
advocacy, industry and academia,” said Lonnie Moulder, CEO of
TESARO. “We are honored and humbled to accept the EY Entrepreneur
of the Year New England Award on behalf of this talented group of
individuals. It is truly a team effort to accomplish what we have
over a relatively short period of time.”
In the seven years since TESARO’s founding, the
company has made significant contributions to patient care through
rapid and responsible product development and commercialization.
Since 2010, TESARO has grown to become a leading oncology-focused
biopharmaceutical company with more than 650 associates across the
U.S. and Europe. TESARO has launched two important oncology
medicines and built out a robust pipeline of oncology and
immuno-oncology candidates, three of which are currently under
review in both the U.S. and Europe.
All regional award winners will move on for
consideration in the Entrepreneur of the Year National program.
Award winners in several national categories, as well as the
Entrepreneur of the Year National Overall Award winner, will be
announced at the Entrepreneur of the Year National Awards on
November 18, 2017. The awards are the culminating event of the
Strategic Growth Forum™, the nation’s most prestigious gathering of
high-growth, market-leading companies.
About EY Entrepreneur of the
Year®EY Entrepreneur of the Year is the world’s most
prestigious business award for entrepreneurs. The unique award
makes a difference through the way it encourages entrepreneurial
activity among those with potential and recognizes the contribution
of people who inspire others with their vision, leadership and
achievement. As the first and only truly global award of its kind,
Entrepreneur of the Year celebrates those who are building and
leading successful, growing and dynamic businesses, recognizing
them through regional, national and global awards programs in more
than 145 cities in more than 60 countries.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
Investor/Media Contact:
Jennifer Davis
Vice President, Corporate Affairs & Investor Relations
+1.781.325.1116 or jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024